Gene · 8451
Papers1,929
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 1,929
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cullin neddylation inhibitor attenuates hyperglycemia by enhancing hepatic insulin signaling through insulin receptor substrate stabilization. | Proc Natl Acad Sci U S A | 2022 | 35115401 | PubTator, text mining | PubMed |
| Human cytomegalovirus protein RL1 degrades the antiviral factor SLFN11 via recruitment of the CRL4 E3 ubiquitin ligase complex. | Proc Natl Acad Sci U S A | 2022 | 35105802 | PubTator, text mining | PubMed |
| DTL Is a Prognostic Biomarker and Promotes Bladder Cancer Progression through Regulating the AKT/mTOR axis. | Oxid Med Cell Longev | 2022 | 35103094 | PubTator, text mining | PubMed |
| Modeling the CRL4A ligase complex to predict target protein ubiquitination induced by cereblon-recruiting PROTACs. | J Biol Chem | 2022 | 35101445 | PubTator, text mining | PubMed |
| HIV-2/SIV Vpx antagonises NF-κB activation by targeting p65. | Retrovirology | 2022 | 35073912 | PubTator, text mining | PubMed |
| Identification of Characteristic Genes in Whole Blood of Intervertebral Disc Degeneration Patients by Weighted Gene Coexpression Network Analysis (WGCNA). | Comput Math Methods Med | 2022 | 35069789 | PubTator, text mining | PubMed |
| Artificial Intelligence Analysis of Gene Expression Predicted the Overall Survival of Mantle Cell Lymphoma and a Large Pan-Cancer Series. | Healthcare (Basel) | 2022 | 35052318 | PubTator, text mining | PubMed |
| PROTAC targeted protein degraders: the past is prologue. | Nat Rev Drug Discov | 2022 | 35042991 | PubTator, text mining | PubMed |
| New insights into the interplay between long non-coding RNAs and RNA-binding proteins in cancer. | Cancer Commun (Lond) | 2022 | 35019235 | PubTator, text mining | PubMed |
| A proximity biotinylation-based approach to identify protein-E3 ligase interactions induced by PROTACs and molecular glues. | Nat Commun | 2022 | 35013300 | PubTator, text mining | PubMed |
| Long non-coding RNA nuclear-enriched abundant transcript 1 (LncRNA NEAT1) upregulates Cyclin T2 (CCNT2) in laryngeal papilloma through sponging miR-577/miR-1224-5p and blocking cell apoptosis. | Bioengineered | 2022 | 35012431 | PubTator, text mining | PubMed |
| Mechanisms of Viral Degradation of Cellular Signal Transducer and Activator of Transcription 2. | Int J Mol Sci | 2022 | 35008916 | PubTator, text mining | PubMed |
| Y chromosome is moving out of sex determination shadow. | Cell Biosci | 2022 | 34983649 | PubTator, text mining | PubMed |
| Development of Photolenalidomide for Cellular Target Identification. | J Am Chem Soc | 2022 | 34978798 | PubTator, text mining | PubMed |
| Rapid, efficient and activation-neutral gene editing of polyclonal primary human resting CD4+ T cells allows complex functional analyses. | Nat Methods | 2022 | 34949807 | PubTator, text mining | PubMed |
| pVHL-mediated SMAD3 degradation suppresses TGF-β signaling. | J Cell Biol | 2022 | 34860252 | PubTator, text mining | PubMed |
| LncRNA LINC00460: Function and mechanism in human cancer. | Thorac Cancer | 2022 | 34821482 | PubTator, text mining | PubMed |
| CDK1/FBXW7 facilitates degradation and ubiquitination of MLST8 to inhibit progression of renal cell carcinoma. | Cancer Sci | 2022 | 34741373 | PubTator, text mining | PubMed |
| Exosome-mediated transfer of SNHG7 enhances docetaxel resistance in lung adenocarcinoma. | Cancer Lett | 2022 | 34715254 | PubTator, text mining | PubMed |
| A Hypoxia-Induced SCFFBXL1 E3 Ligase Ubiquitinates and Degrades the MEN1 Tumor Suppressor to Promote Colorectal Cancer Tumorigenesis. | Cancer Res Treat | 2022 | 34237211 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8451/papers?page=21